title: Confounding effect of cyclosporine dosing when comparing horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.
authors.affiliation: Institute of Pediatric Hematology and Oncology, Lyon, France UMR 5558, Lyon I University, Villeurbanne, France nathalie.bleyzac@chu-lyon.fr.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Bleyzac
authors.affiliation: UMR 5558, Lyon I University, Villeurbanne, France.
authors.forename: Michaël
authors.initials: M
authors.lastname: Philippe
authors.affiliation: Institute of Pediatric Hematology and Oncology, Lyon, France.
authors.forename: Amandine
authors.initials: A
authors.lastname: Bertrand
authors.affiliation: Institute of Pediatric Hematology and Oncology, Lyon, France.
authors.forename: Yves
authors.initials: Y
authors.lastname: Bertrand
mesh_terms: D000741:Anemia, Aplastic / Q000188:drug therapy*; D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D016176:T-Lymphocyte Subsets / Q000187:drug effects*
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents
keywords: aplastic anemia; cyclosporine; pharmacokinetics; regulatory T cells